The author discusses improving erythropoiesis through iron chelation in myelofibrosis (MF). Topics discussed include iron overload resulting from red cell transfusion dependency is common in the fibrotic stages of MF, and iron chelation not being used uniformly in iron-overloaded patients with MF due to its side effects.